Russia's pharmaceutical market reached 1.344 trillion rubles in 2016, an increase of 7% over the same period of 2007. The annual sales volume was basically the same as that of 2015, reaching 5.1 billion bales. The growth of the market mainly came from the sales of the commercial sector. The sales growth in the retail market was in good growth, The growth mainly comes from non-prescription drugs. At present, the market has seen a growth trend in the context of a decrease in sales of original research drugs.
Another trend in 2016 is the growth in the sales of homegrown medicines in Russia, with sales and sales accounting for 29% and 61% of the market, respectively. Pharmaceutical import substitution has been fruitful in recent years with the share of imported medicines declining year by year, replaced by localization The growth in the production of pharmaceuticals has benefited from the 'restrictions on the entry of imported drugs into the government procurement ordinance' ('There are two or more indigenous companies that bid out and the importing company is no longer involved') .Although domestic companies are also developing, multinationals Still dominate the market, such as Sanofi, Novartis and Bayer.
In the distribution and pharmacy chain markets, there is a growing trend of concentration in 2016. The field of pharmaceutical distribution in Russia has undergone tremendous changes over the past few years, with three local sales companies entering the top 20 in the past two years Strong, fill the gap.These three companies among the top three, from 45% market share in 2015 increased to 56% in 2016, the three largest sales companies also fierce competition between the number one Protek sales Accounting for 21.5%, the second Katren company slightly lower, accounting for 21.2%, Пульс company rapid growth in recent years, accounting for 13.3% share.
In addition, the integration of pharmacy chains has become a major trend in 2016. The independent pharmacy association ASNA achieved the best result in pharmacy consortium and pharmacy chain with 4,215 sales outlets, accounting for 7.8% of the market, of which, 36.6% of pharmacies Highest, reaching 4.7%.
